Overview
- 9 FDA inspections are on record.
- 4 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-08-29.
At a glance
Inspections
9
Form 483s
4
EIRs
1
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 18 Aug 2025 – 29 Aug 2025 | Medical Devices & Rad Health | 483 | View 483 → |
| 11 Dec 2023 – 22 Jan 2024 | Medical Devices & Rad Health | 483 | View 483 → |
| 28 Mar 2022 – 6 Apr 2022 | Medical Devices & Rad Health | 483 | On file |
| 23 May 2016 – 26 May 2016 | Medical Devices & Rad Health | Clean | |
| 7 Mar 2013 – 20 Mar 2013 | Medical Devices & Rad Health | Clean | |
| 21 Jan 2011 | Not recorded | Clean | |
| 8 Mar 2010 | Not recorded | Clean | |
| 11 Dec 2008 | Not recorded | 483 | View 483 → |
| 25 Mar 2003 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
29 Aug 2025
21 CFR 803.50(a)(1)
Report of Death or Serious Injury
Cited by Edward E Lockwood, Michelle J Glembin
29 Aug 2025
21 CFR 820.100(a)
Lack of or inadequate procedures
Cited by Edward E Lockwood, Michelle J Glembin
29 Aug 2025
21 CFR 820.198(a)
Lack of or inadequate complaint procedures
Cited by Edward E Lockwood, Michelle J Glembin
29 Aug 2025
21 CFR 820.50
Purchasing controls, Lack of or inadequate procedures
Cited by Edward E Lockwood, Michelle J Glembin
29 Aug 2025
21 CFR 820.90(a)
Nonconforming product control
Cited by Edward E Lockwood, Michelle J Glembin
Investigators
FDA investigators tied to this site in the record.
Stephen D Eich3 insp.
Michelle J Glembin2 insp.
Natasha R Johnson2 insp.
Edward E Lockwood1 insp.
Nicholas Z Lu1 insp.
Patricia A Mcilroy1 insp.
Andrew A Leboeuf1 insp.
Jesse A Vazquez1 insp.
Jeanne J Chiu1 insp.
Sherea L Dillon1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 820.50 | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 820.100(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.198(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 803.50(a)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 803.50(a)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.100(a)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.100(a)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.30(i) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.50(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.70(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.90(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Medline Industries, LP's 4 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat